Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

A longitudinal study highlights shared aspects of the transcriptomic response to cardiogenic and septic shock.

Braga D, Barcella M, Herpain A, Aletti F, Kistler EB, Bollen Pinto B, Bendjelid K, Barlassina C.

Crit Care. 2019 Dec 19;23(1):414. doi: 10.1186/s13054-019-2670-8.

2.

Enteral Tranexamic Acid Decreases Proteolytic Activity in the Heart in Acute Experimental Hemorrhagic Shock.

Aletti F, Santamaria M, Chin K, Mazor R, Kistler EB.

J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):484-493. doi: 10.1177/1074248419841630. Epub 2019 Apr 29.

PMID:
31035788
3.

Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality.

Bauzá-Martinez J, Aletti F, Pinto BB, Ribas V, Odena MA, Díaz R, Romay E, Ferrer R, Kistler EB, Tedeschi G, Schmid-Schönbein GW, Herpain A, Bendjelid K, de Oliveira E.

Br J Anaesth. 2018 Nov;121(5):1065-1074. doi: 10.1016/j.bja.2018.05.072. Epub 2018 Jul 26.

4.

Cleavage of the leptin receptor by matrix metalloproteinase-2 promotes leptin resistance and obesity in mice.

Mazor R, Friedmann-Morvinski D, Alsaigh T, Kleifeld O, Kistler EB, Rousso-Noori L, Huang C, Li JB, Verma IM, Schmid-Schönbein GW.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaah6324. doi: 10.1126/scitranslmed.aah6324.

PMID:
30135249
5.

Preliminary profiling of blood transcriptome in a rat model of hemorrhagic shock.

Braga D, Barcella M, D'Avila F, Lupoli S, Tagliaferri F, Santamaria MH, DeLano FA, Baselli G, Schmid-Schönbein GW, Kistler EB, Aletti F, Barlassina C.

Exp Biol Med (Maywood). 2017 Aug;242(14):1462-1470. doi: 10.1177/1535370217717978. Epub 2017 Jun 29.

6.

Severity of Acute Kidney Injury in the Post-Lung Transplant Patient Is Associated With Higher Healthcare Resources and Cost.

Nguyen AP, Gabriel RA, Golts E, Kistler EB, Schmidt U.

J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1361-1369. doi: 10.1053/j.jvca.2017.02.004. Epub 2017 Feb 5.

PMID:
28455097
7.

Enteral tranexamic acid attenuates vasopressor resistance and changes in α1-adrenergic receptor expression in hemorrhagic shock.

Santamaria MH, Aletti F, Li JB, Tan A, Chang M, Leon J, Schmid-Schönbein GW, Kistler EB.

J Trauma Acute Care Surg. 2017 Aug;83(2):263-270. doi: 10.1097/TA.0000000000001513.

8.

Set up of a protocol for rat plasma peptidomics in hemorrhagic shock model in presence of heparin.

Maffioli E, Aletti F, Santagata F, Negri A, Santamaria MH, De Lano FA, Kistler EB, Schmid-Schönbein GW, Tedeschi G.

EuPA Open Proteom. 2016 Mar 16;12:1-3. doi: 10.1016/j.euprot.2016.03.004. eCollection 2016 Sep.

9.

Peptidomic Analysis of Rat Plasma: Proteolysis in Hemorrhagic Shock.

Aletti F, Maffioli E, Negri A, Santamaria MH, DeLano FA, Kistler EB, Schmid-Schönbein GW, Tedeschi G.

Shock. 2016 May;45(5):540-54. doi: 10.1097/SHK.0000000000000532.

10.

Heparin Interaction with the Primed Polymorphonuclear Leukocyte CD11b Induces Apoptosis and Prevents Cell Activation.

Cohen-Mazor M, Mazor R, Kristal B, Kistler EB, Ziv I, Chezar J, Sela S.

J Immunol Res. 2015;2015:751014. doi: 10.1155/2015/751014. Epub 2015 Dec 27.

11.

Autodigestion: Proteolytic Degradation and Multiple Organ Failure in Shock.

Altshuler AE, Kistler EB, Schmid-Schönbein GW.

Shock. 2016 May;45(5):483-9. doi: 10.1097/SHK.0000000000000544. Review.

12.

In vivo analysis of intestinal permeability following hemorrhagic shock.

Alsaigh T, Chang M, Richter M, Mazor R, Kistler EB.

World J Crit Care Med. 2015 Nov 4;4(4):287-95. doi: 10.5492/wjccm.v4.i4.287. eCollection 2015 Nov 4.

13.

Replacing the Transfusion of 1-2 Units of Blood with Plasma Expanders that Increase Oxygen Delivery Capacity: Evidence from Experimental Studies.

Tsai AG, Salazar Vázquez BY, Cabrales P, Kistler EB, Tartakovsky DM, Subramaniam S, Acharya SA, Intaglietta M.

J Funct Biomater. 2014 Oct 27;5(4):232-45. doi: 10.3390/jfb5040232. Review.

14.

Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells.

Mazor R, Alsaigh T, Shaked H, Altshuler AE, Pocock ES, Kistler EB, Karin M, Schmid-Schönbein GW.

J Biol Chem. 2013 Jan 4;288(1):598-607. doi: 10.1074/jbc.M112.417451. Epub 2012 Nov 15.

15.

Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine.

Chang M, Alsaigh T, Kistler EB, Schmid-Schönbein GW.

PLoS One. 2012;7(6):e40087. doi: 10.1371/journal.pone.0040087. Epub 2012 Jun 29.

16.

Impaired small-bowel barrier integrity in the presence of lumenal pancreatic digestive enzymes leads to circulatory shock.

Kistler EB, Alsaigh T, Chang M, Schmid-Schönbein GW.

Shock. 2012 Aug;38(3):262-7. doi: 10.1097/SHK.0b013e31825b1717.

17.

Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall.

Chang M, Kistler EB, Schmid-Schönbein GW.

Shock. 2012 Mar;37(3):297-305. doi: 10.1097/SHK.0b013e318240b59b.

18.

Limitations of volumetric indices obtained by trans-thoracic thermodilution.

Bigatello LM, Kistler EB, Noto A.

Minerva Anestesiol. 2010 Nov;76(11):945-9. Review.

19.
20.

Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock.

Schmid-Schönbein GW, Kistler EB, Hugli TE.

Biorheology. 2001;38(2-3):185-201.

PMID:
11381174
21.

Pancreatic enzymes and microvascular cell activation in multiorgan failure.

Schmid-Schönbein GW, Hugli TE, Kistler EB, Sofianos A, Mitsuoka H.

Microcirculation. 2001 Feb;8(1):5-14. Review.

PMID:
11296853
22.

Plasma activation during splanchnic arterial occlusion shock.

Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW.

Shock. 2000 Jul;14(1):30-4.

PMID:
10909890
23.

The pancreas as a source of cardiovascular cell activating factors.

Kistler EB, Hugli TE, Schmid-Schönbein GW.

Microcirculation. 2000 Jun;7(3):183-92.

PMID:
10901497
24.

Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes.

Mitsuoka H, Kistler EB, Schmid-Schonbein GW.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1772-7.

Supplemental Content

Loading ...
Support Center